Susan G. Komen helps people with any stage of breast cancer find and participate in clinical trials, including trials supported by Komen.
Diagnosed with Metastatic Breast Cancer at 43 years old, Sheila McGlown talks about her experience with clinical trials and shares that it wasn’t a last resort in her treatment journey.
It is not that Hispanics do not want to participate; we need to be invited to participate.’’
People who join clinical trials receive high-quality care,
and at the same time are contributing to research that
could help themselves or others.
Meet Sandi Spivey, initially diagnosed with breast cancer
in 1995 and with metastatic breast cancer in 1998, as she
talks about her personal experience with clinical trials.
Early findings from the Komen-funded RxPONDER (Rx for Positive Node, Endocrine Responsive Breast Cancer) study indicate some postmenopausal women with lymph node-positive, hormone receptor-positive, HER2-negative breast cancer do not benefit from chemotherapy when it is added to hormone therapy. These women may be able to safely avoid chemotherapy and its harmful side effects. In contrast, premenopausal women benefitted from chemotherapy.
If you or a loved one needs information or resources about
clinical trials, call our Clinical Trial Information
Helpline at 1-877 GO KOMEN (1-877- 465- 6636) or email
Call our Clinical Trial Information Helpline to speak with a
or email at
The Helpline offers breast cancer clinical trial education and
support, such as:
Breast cancer patients at any stage can join a clinical trial.
Breast cancer clinical trials study prevention, new screening
tests and treatment options, as well as quality of life issues.
Learn more about other featured breast cancer clinical trials.